Moderna lawsuits could leave taxpayers on the hook after company made billions

Brasil Notícia Notícia

Moderna lawsuits could leave taxpayers on the hook after company made billions
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 FoxBusiness
  • ⏱ Reading Time:
  • 36 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 53%

Moderna faces multiple lawsuits over its COVID-19 vaccine which could leave taxpayers paying the tab.

That may surprise many American taxpayers. Moderna had $17.7 billion in revenue from vaccine sales in 2021 and predicted it would bring in at least $19 billion in 2022.

"Not only has it got this public-private partnership issue that's still hovering in the background with the NIH, it's also got all this, this private litigation that's going on, which could impact how it develops its future technologies in terms of other products outside of COVID," Tahir Amin, a co-executive director of I-MAK told Fox News in an interview.

"There was a significant amount of funding, as I said, to some $2.5 billion that the government gave to Moderna to kind of help them push the research and development along. Some of that research and some of the technology that goes into the vaccine was actually developed by, like I said, at the NIH.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

FoxBusiness /  🏆 458. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Moderna seeks FDA approval for COVID-19 vaccine for children under 6Moderna seeks FDA approval for COVID-19 vaccine for children under 6COVID-19 vaccine developer Moderna has requested expanded authorization to give its two-dose vaccine to children ages 5 and under, a highly anticipated step toward vaccinating the only age group remaining ineligible.
Consulte Mais informação »

Moderna aims for Fall release for omicron, variant-specific COVID-19 vaccine boostersModerna aims for Fall release for omicron, variant-specific COVID-19 vaccine boostersThe US could spend between $5 billion to $12 billion on distributing updated vaccines.
Consulte Mais informação »

Amazon ends paid COVID-19 leave policy for workers | EngadgetAmazon ends paid COVID-19 leave policy for workers | EngadgetAs of May 2nd, Amazon will no longer offer paid time off for workers who test positive for COVID-19..
Consulte Mais informação »

Coronavirus: Amazon nixes paid COVID-19 leave for US employeesCoronavirus: Amazon nixes paid COVID-19 leave for US employeesAmazon will no longer grant up to seven days of paid time off for U.S. workers infected with COVID-19, the company announced in an internal Saturday memo
Consulte Mais informação »

Amazon Terminated Paid Sick Leave for Covid-19 Day After Union Vote EndedAmazon Terminated Paid Sick Leave for Covid-19 Day After Union Vote EndedThe National Labor Relations Board began counting ballots Monday at LDJ5, a Staten Island facility looking to become the second Amazon location to win a union election in the U.S.
Consulte Mais informação »

Amazon ends its paid Covid-19 sick leave policyAmazon ends its paid Covid-19 sick leave policyThe return to pre-pandemic sick leave policies means that all US Amazon employees will now get up to five days of excused, unpaid time off for a confirmed Covid-19 diagnosis.
Consulte Mais informação »



Render Time: 2025-03-09 07:52:58